These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10210500)

  • 21. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of ventricular fibrillation duration and a preceding unsuccessful shock on the probability of defibrillation success using biphasic waveforms in pigs.
    Windecker S; Kay GN; KenKnight BH; Walcott GP; Smith WM; Ideker RE
    J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1386-95. PubMed ID: 9436776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncated biphasic pulses for transthoracic defibrillation.
    Bardy GH; Gliner BE; Kudenchuk PJ; Poole JE; Dolack GL; Jones GK; Anderson J; Troutman C; Johnson G
    Circulation; 1995 Mar; 91(6):1768-74. PubMed ID: 7882486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac parasympathetic stimulation via QRS-synchronous low-energy shocks in humans.
    Friedman PA; Hill MR; Stanton MS
    J Cardiovasc Electrophysiol; 1999 Jan; 10(1):10-6. PubMed ID: 9930904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds.
    Kudenchuk PJ; Poole JE; Dolack GL; Gleva MJ; Anderson J; Troutman C; Bardy GH
    J Cardiovasc Electrophysiol; 1997 May; 8(5):485-95. PubMed ID: 9160224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pulse separation between two sequential biphasic shocks given over different lead configurations on ventricular defibrillation efficacy.
    Johnson EE; Alferness CA; Wolf PD; Smith WM; Ideker RE
    Circulation; 1992 Jun; 85(6):2267-74. PubMed ID: 1591840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety margins: lessons from the Low Energy Endotak Trial (LEET).
    Neuzner J
    Am J Cardiol; 1996 Sep; 78(5A):26-32. PubMed ID: 8820833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation.
    Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC
    Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of noncommitted shocks for nonsustained ventricular arrhythmias by a new implantable cardioverter defibrillator with abortive shock capability.
    Blanck Z; Biehl M; Sra J; Dhala A; Akhtar M
    J Cardiovasc Electrophysiol; 1997 Mar; 8(3):317-22. PubMed ID: 9083881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-energy defibrillation increases the dispersion of regional ventricular repolarization.
    Pang Y; Jin Q; Zhang N; Ren S; Ling T; Chen Y; Gu G; Shen Y; Wu L
    J Interv Card Electrophysiol; 2011 Nov; 32(2):81-6. PubMed ID: 21671072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of shock timing on defibrillation success.
    Hsu W; Lin Y; Heil JE; Jones J; Lang DJ
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):153-7. PubMed ID: 9121980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term evaluation of the ventricular defibrillation energy requirement.
    Tokano T; Pelosi F; Flemming M; Horwood L; Souza JJ; Zivin A; Knight BP; Goyal R; Man KC; Morady F; Strickberger SA
    J Cardiovasc Electrophysiol; 1998 Sep; 9(9):916-20. PubMed ID: 9786072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators.
    Gold MR; Breiter D; Leman R; Rashba EJ; Shorofsky SR; Hahn SJ
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):483-6. PubMed ID: 12687873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with a third-generation implantable cardioverter-defibrillator.
    Saksena S; Mehta D; Krol RB; Tullo NG; Saxena A; Kaushik R; Neglia J
    Am J Cardiol; 1991 Jun; 67(16):1375-84. PubMed ID: 2042568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
    Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA
    Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.